Goyescas Broncovac 3
Product Images NDC 11856-0025

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Goyescas Broncovac 3 (NDC 11856-0025). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Goyescas Of Fla, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Carton (Goyescas Broncovac 3 6 Oz. Carton 001)

Carton (Goyescas Broncovac 3 6 Oz. Carton 001)
Broncovac is a cough and cold medication containing Dextromethorphan HBr, Guaitenesin, and Phenylephrine HCI. It's used to loosen phlegm and thin bronchial secretions to help with nasal congestion and cough due to minor throat and bronchia irritation. The medication is free of alcohol and contains bee honey, ginger, and echinacea. The dosage and directions depend on age and should be followed as directed by a doctor. It is important to read the warnings before use and keep it out of reach of children. The inactive ingredients include glycerin, purified water, and sucralose. The medication comes in a bottle size of 6 fl. onz. and it is distributed by Goyescas Corp.*
FDA Label Image

Label (Goyescas Broncovac 3 6 Oz. Label 001)

Label (Goyescas Broncovac 3 6 Oz. Label 001)
This is a drug facts label for a cold and cough expectorant. It includes the active ingredients and their purposes, which are dextromethorphan HBr USP (10mg), guaifenesin USP (100mg), and phenylephrine HCI USP (5mg). This expectorant can help with symptoms such as cough, nasal congestion, and bronchial irritation by loosening phlegm and thinning bronchial secretions to help drain bronchial tubes. There are warnings to not use this medicine with certain drugs used for depression, emotional conditions, Parkinson's disease, or up to two weeks after stopping (MAOI) drugs. The directions for dosage depend on age and are provided on the label, along with a list of inactive ingredients.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.